IDO2 and cancer: CD8A expression is correlated with all three genes in 22 cancer types, and with IDO-1 and IDO-2 (but not TDO-2) in nine more cancer types, so CD8+ T-cell infiltration is likely a widespread predictor of IDO pathway over-expression.